Recently, SLC7A11 was also reported to be involved in the sensitivity to the histone deacetylase inhibitors [45]; thus, the pharmacological blockade of SLC7A11 not only inhibits tumor growth, but also reverses resistance to certain drugs. Here, SLC7A11 is linked to neoplasm.